Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Universal Ibogaine Inc V.IBO

Alternate Symbol(s):  IBOGF

Universal Ibogaine Inc. is a Canada-based life sciences company. The Company is focused on developing a network of addiction treatment clinics and undertake a planned clinical trial for research into the use of ibogaine for addiction treatment. Ibogaine is a naturally-occurring molecule derived from the root bark of the iboga tree and other plants. Ibogaine is a neuroactive compound that appears to reset the brains of drug dependent individuals to a pre-addicted state. Ibogaine has demonstrated effectiveness in treating opioid use disorder and it appears to eliminate the painful symptoms of opioid withdrawal and provides a several month window free of drug cravings. Ibogaine targets multiple receptor sites in the brain when it manages dopamine and serotonin circuits and stimulates new brain cell growth.


TSXV:IBO - Post by User

Post by MarketGainson Mar 09, 2022 2:19am
121 Views
Post# 34498199

Universal Ibogaine Webcast @ VirtualInvestorConferences.com

Universal Ibogaine Webcast @ VirtualInvestorConferences.com

User image

 


Universal Ibogaine Inc. to Webcast Live at OTC Markets VirtualInvestorConferences.com March 10th 



Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.com

 

Vancouver B.C., March 08, 2022 — Universal Ibogaine (OTCQB:IBOGF) (TSX-V:IBO) (FSE:JC4), a life sciences company based in Canada, focused on transforming the addiction treatment industry through the medical use of the plant medicine ibogaine, today announced that Nick Karos Name, Chief Executive Officer, will present live at OTC Markets VirtualInvestorConferences.com on March 10th, 2022.

Article content

 

DATE: March 10th, 2022
TIME: 12:00 PM EST
LINK:
https://bit.ly/3CjIH4R

 

This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.

 

Event attendees will also be able to schedule 1 on 1 meetings with the Investor Relations team which will take place on Friday March 11, Monday March 14, and Tuesday March 15.

 

It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates.

 

Learn more about the event at www.virtualinvestorconferences.com.

 

Recent Company Highlights

Article content

 

About Universal Ibogaine

 

Universal Ibogaine is a life sciences company, with a mission to demonstrate the safety and efficacy of its ibogaine based drug detox protocol through a planned Canadian Clinical Trial, and ultimately to utilize that protocol around the globe through future licensing agreements.  UI is concurrently developing a state of the art holistic addiction treatment protocol at its Kelburn Clinic that, which when paired with the planned ibogaine detox protocol, is intended to revolutionize the way we treat addiction and drastically improve the lives of individuals and families affected by addiction. 

Article content

 

About Virtual Investor Conferences®
Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors.

 

Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access.  Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors.

 

CONTACTS:

 

Universal Ibogaine
Dugan Selkirk
Investor Relations Manager
1-855-426-4246
dugan.selkirk@universalibogaine.com

 

Virtual Investor Conferences
John M. Viglotti
SVP Corporate Services, Investor Access
OTC Markets Group
(212) 220-2221
johnv@otcmarkets.com

 
<< Previous
Bullboard Posts
Next >>